Chengda Zhang

Biography

Chengda Zhang (张程达) is a clinical informatics fellow at OHSU. He earned his M.D. degree from Peking Union Medical College, Tsinghua University in 2015. Later he completed a residency in internal medicine at Beaumont Health, Oakland University William Beaumont School of Medicine in 2019. And subsequently a fellowship in critical care medicine at OHSU in 2021.

Along his medicine training, he became interested in clinical informatics. As a fellow in clinical informatics, he plan to explore all aspects of the specialty, as well as the evolving information technologies in the research and teaching of medicine.

Education

  • M.D., 2015, Peking Union Medical College, Tsinghua University
  • Internship:

    • Internal medicine, Beaumont Health, Oakland University William Beaumont School of Medicine, Royal Oak MI, 2017
  • Residency:

    • Internal medicine, Beaumont Health, Oakland University William Beaumont School of Medicine, Royal Oak MI, 2019
  • Fellowship:

    • Critical care medicine, OHSU, Portland OR, 2021
  • Certifications:

    • Emergency Neurological Life Support (ENLS) by Neurocritical Care Society. Certificate earned in May 2020
    • Examination of Special Competence in Critical Care Echocardiography. Testamur status by National Board of Echocardiography. Certificate earned in Mar 2020
    • SNOMED CT Foundation Course, by SNOMED International. Certificate earned on 08/31/2020
    • SQL for Data Science, by UC Davis on Coursera. Certificate earned on 08/18/2020

Memberships and associations

  • Society of Critical Care Medicine
  • American Medical Informatics Association

Areas of interest

  • data science
  • machine learning
  • critical care informatics
  • telemedicine

Publications

Selected publications

  • Zhang C, Chow FC, Han Y, Xie J, Qiu Z, Guo F, et al.. Multicenter Cohort Study of Diabetes Mellitus and Impaired Fasting Glucose in HIV-infected Patients in China. J Acquir Immune Defic Syndr. 2015 68(3): 298-303
  • Zhang C, Wang W, Zhou M, Han Y, Xie J, Qiu Z, et al.. The interaction of CD4 T-cell count and nevirapine hepatotoxicity in China: a change in national treatment guidelines may be warranted. J Acquir Immune Defic Syndr. 2013,62:540-545.

Publications

  • {{ pub.journalAssociation.journal.name.text[0].value }}